I am a Kent State University graduate (2021) with a Bachelor's degree in Biology and an Associate of Science degree. Currently, I work as a Software Developer in Clinical Research at the Cole Eye Institute, where I specialize in building machine learning models for image analysis and post-surgical assessment.
I have designed and implemented specialized software solutions that are patent pending and support ophthalmic research. My software has played a key role in multiple research publications, patents and presentations. I am passionate about leveraging my programming skills along with my biology background to drive innovation in image analysis.
Independence Phlebotomy USA, Independence, OH
Kent State University, Kent, OH
Kent State University, Kent, OH
Developed a deep learning model that generates binary vessel masks from multi-modal ophthalmic imaging. Extended the pipeline to perform artery/vein classification and compute quantitative vessel metrics for downstream analysis.
Developed a software tool that generates en face images from OCT B-scan volumes, with the ability to segment disease on the en face view. Segmented regions are projected back onto the corresponding B-scans to localize pathology within the original scan.
Developed tool for pre/post-treatment comparison of sarcoid lesions with interactive GUI and real-time threshold adjustment for lesion segmentation. Implemented red/green tinting for direct visualization of lesion changes.
Developed measurement tool for quantifying premacular bursa dimensions on OCT slices with scaling solutions for accurate measurements. Implemented user-friendly interface for research use.
Contributed to the development of a novel risk assessment tool for cardiovascular events using ophthalmic imaging. Created models to generate binary vessel masks and artery/vein segmentation from fundus images.
Singh S, Barbosa GCS, Mammo DA, Whitney J, Baynes K, Sharma S, Srivastava SK. Choroidal vessel thickness changes on indocyanine green angiography after scleral windows for uveal effusion syndrome. J Vitreoretin Dis. 2026 May 7:24741264261438461. doi:10.1177/24741264261438461. Online ahead of print.
Read Journal ArticleMizuno Y, Srivastava SK, Singh S, et al. Swept-source OCT and OCT angiography B-scan analysis of inflammatory retinal vascular changes: quantitative and qualitative assessment. Ophthalmol Retina. 2026;10(5):552-561. doi:10.1016/j.oret.2026.01.006.
Read Journal ArticleShin D, Shen J, Mohan N, Bellanda V, Schulgit MJ, Chen C, Sanchez E, Mizuno Y, Singh S, et al. Glucagon-like peptide-1 receptor agonists in type 2 diabetes and incidence of non-arteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2026;67(7):3109.
Read ARVO AbstractBellanda V, Chen C, Mizuno Y, Shin D, Barbosa GCS, Sanchez E, Mohan N, Schulgit MJ, Singh S, et al. Longitudinal analysis of ellipsoid zone loss in Stargardt disease. Invest Ophthalmol Vis Sci. 2026;67(7):5361.
Read ARVO AbstractSingh S, Bellanda V, Mizuno Y, Chen C, Baynes K, Srivastava SK, Sharma S. Towards objective fundus autofluorescence grading: a semiautomated tool for quantitative assessment of retinal disease. Invest Ophthalmol Vis Sci. 2026;67(7):3985.
Read ARVO AbstractMohan N, Schulgit MJ, Singh S, Bellanda V, Chen C, Shin D, Chaudhury P, Yuan A, Srivastava SK, Sharma S. Longitudinal retinal vascular changes on fundus photo after statin initiation. Invest Ophthalmol Vis Sci. 2026;67(7):3575.
Read ARVO AbstractSchulgit MJ, Mohan N, Singh S, Bellanda V, Chen C, Shin D, Sanchez E, Haddad E, Cameron S, Nowacki A, Srivastava SK, Sharma S. Impact of systemic blood pressure control on the retinal vasculature. Invest Ophthalmol Vis Sci. 2026;67(7):3573.
Read ARVO AbstractAntaki F, Arline AA, Bala S, Mohan N, Schulgit MJ, Bellanda VCF, Mahmoud M, Singh S, et al. Scalable and Automated Extraction of Clinical Features from Ocular Candidiasis Screening Consultations Using Large Language Models. AAO 2025. Abstract Id: 30082430.
Delaney A, Singh S, et al. Screening for retinal ischemic perivascular lesions in patients undergoing cardiovascular assessment: A one-year outcome analysis. ASRS 2025 43rd Annual Scientific Meeting. Proposal.
Mizuno Y, Singh S, et al. Optical coherence tomography angiography findings in retinal vasculitis. ASRS 2025 43rd Annual Scientific Meeting. Proposal.
Srivastava SK, Sharma S, Baynes KM, Singh S, et al. OCT and OCT-A of the Retina in Patients Undergoing Cardiovascular Studies: A Prospective Study. AAO 2024. Abstract 30079813.
Sharma S, Hamden A, Chen C, Singh S, et al. Longitudinal quantitative anterior chamber cell analysis following Vamikibart intravitreal therapy in patients with uveitic macular edema from the DOVETAIL clinical trial. Invest Ophthalmol Vis Sci. 2024;65(7):3028.
Read ARVO AbstractSingh S, Sharma S, Baynes K, et al. Imaging characteristics and clinical utility of full-dose vs quarter-dose ultra-widefield fluorescein angiography. Invest Ophthalmol Vis Sci. 2024;65(7):5959.
Read ARVO AbstractSzigiato A, Sharma S, Singh S, et al. Imaging characteristics and clinical utility of half-dose versus full-dose ultrawidefield fundus fluorescein angiography. Ophthalmol Retina. 2024;8(10):981-986. doi:10.1016/j.oret.2024.04.024.
Read Journal ArticleErwin C, Sharma S, McDonald MA, Singh S, et al. Remote assessment of patients with red eyes utilizing anterior segment optical coherence tomography – a pilot study. Invest Ophthalmol Vis Sci. 2023;64(8):3408.
Read ARVO AbstractSzigiato A, Singh S, Mills M, et al. Imaging characteristics and clinical utility of half vs full dose ultra-widefield fluorescein angiography. Invest Ophthalmol Vis Sci. 2023;64(8):3730.
Read ARVO AbstractSingh S, Mammo D, Baynes K, et al. The change in choroidal vessel thickness on ICG angiography in patients who underwent scleral windows for uveal effusion syndrome. Invest Ophthalmol Vis Sci. 2023;64(8):2084.
Read ARVO Abstract